Sarepta Therapeutics Inc (SRPT)
118.60
+1.74
(+1.49%)
USD |
NASDAQ |
Apr 23, 12:51
Sarepta Therapeutics Shares Outstanding: 93.86M for Feb. 23, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 23, 2024 | 93.86M |
December 31, 2023 | 93.73M |
October 27, 2023 | 93.55M |
September 30, 2023 | 93.54M |
July 28, 2023 | 93.28M |
June 30, 2023 | 93.27M |
April 27, 2023 | 93.15M |
April 14, 2023 | 93.14M |
March 31, 2023 | 93.14M |
March 07, 2023 | 91.83M |
February 23, 2023 | 87.98M |
December 31, 2022 | 87.95M |
October 28, 2022 | 87.78M |
September 30, 2022 | 87.77M |
July 29, 2022 | 87.57M |
June 30, 2022 | 87.54M |
April 29, 2022 | 87.50M |
April 19, 2022 | 87.50M |
April 08, 2022 | 87.50M |
March 31, 2022 | 87.50M |
February 24, 2022 | 87.15M |
December 31, 2021 | 87.13M |
October 29, 2021 | 87.08M |
October 18, 2021 | 87.06M |
September 30, 2021 | 79.96M |
Date | Value |
---|---|
July 30, 2021 | 79.84M |
June 30, 2021 | 79.83M |
April 30, 2021 | 79.77M |
April 12, 2021 | 79.75M |
April 09, 2021 | 79.75M |
March 31, 2021 | 79.75M |
February 19, 2021 | 79.42M |
December 31, 2020 | 79.37M |
October 30, 2020 | 78.91M |
September 30, 2020 | 78.79M |
July 31, 2020 | 78.51M |
June 30, 2020 | 78.43M |
May 01, 2020 | 77.99M |
April 13, 2020 | 77.96M |
April 06, 2020 | 77.96M |
March 31, 2020 | 77.96M |
February 21, 2020 | 77.78M |
February 14, 2020 | 77.07M |
December 31, 2019 | 75.18M |
November 04, 2019 | 74.54M |
September 30, 2019 | 74.50M |
August 02, 2019 | 74.34M |
June 30, 2019 | 74.33M |
May 03, 2019 | 74.15M |
April 11, 2019 | 74.14M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
74.15M
Minimum
May 03 2019
93.86M
Maximum
Feb 23 2024
83.74M
Average
79.96M
Median
Sep 30 2021
Shares Outstanding Benchmarks
PTC Therapeutics Inc | 76.61M |
Vertex Pharmaceuticals Inc | 258.31M |
Regenxbio Inc | 48.99M |
CytomX Therapeutics Inc | 67.72M |
Apellis Pharmaceuticals Inc | 120.58M |